Table 3 Infant outcomes
From: Pharmacovigilance of artemether-lumefantrine in pregnant women followed until delivery in Rwanda
Study groups | |||
|---|---|---|---|
Pregnant women treated with AL for malaria (n = 1072) | Pregnant women without AL treatment (n = 978) | P value | |
Total congenital malformations | 3 (0.3%) | 3 (0.3%) | NS |
Congenital aglossia | 1 (0.09%) | 0 | |
Spina bifida | 0 | 1 (0.1%) | |
Thoracic asymmetry | 0 | 1 (0.1%) | |
Congenital malformation of left foot | 1 (0.09%) | 0 | |
Hydrocephalus (stillbirth baby) | 1(0.09%) | 0 | |
Neurological disorder | 0 | 1 (0.1%) | |
Twins | 9 (0.8%) (one still birth twin) | 3 (0.3%) | NS |
Fetal distress | 3 (0.3%) | 2(0.2%) | NS |